ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
LOE Approachingfexofenadine hydrochloride and pseudoephedrine hydrochloride
NDAORALTABLET, EXTENDED RELEASE
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride and pseudoephedrine hydrochloride) by Sanofi. Approved for these symptoms due to hay fever, other upper respiratory allergies: ▪ runny nose ▪ sneezing ▪ itchy, watery eyes ▪ itching of the nose and 4 more indications. First approved in 1997.
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Allegra-D 12 Hour is a fixed-dose combination of fexofenadine hydrochloride (a non-sedating antihistamine) and pseudoephedrine hydrochloride (a nasal decongestant) delivered as an extended-release oral tablet. It treats symptoms of hay fever and upper respiratory allergies including runny nose, sneezing, itchy/watery eyes, nasal congestion, and sinus pressure. The combination addresses both allergic and congestion symptoms with a single 12-hour dose.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating downsizing marketing investment and team consolidation ahead.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.